Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?
Diabetic retinopathy (DR), one of the most common complications of diabetes mellitus, is characterized by degeneration of retinal neurons and neoangiogenesis. Until today, the pharmacological approaches for DR are limited and focused on counteracting the end-stage of this neurodegenerative disease,...
Saved in:
Main Authors: | F. Fahmideh (Author), N. Marchesi (Author), L. I. M. Campagnoli (Author), L. Landini (Author), C. Caramella (Author), A. Barbieri (Author), S. Govoni (Author), A. Pascale (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy
by: Claudio Bucolo, et al.
Published: (2021) -
Pharmacological Versus Non-Pharmacological and Ancillary Mechanisms in Eye Drops Used in the Treatment of Glaucoma
by: Nicoletta Marchesi, et al.
Published: (2022) -
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018) -
LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy
by: Qiaoyun Gong, et al.
Published: (2020) -
Chapter Hyperglycemia-Induced Endothelial Dysfunction
by: Gero, Domokos
Published: (2018)